Back to Journals » Drug Design, Development and Therapy » Volume 12
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Schisandrin B protects against angiotensin II-induced endotheliocyte deficits by targeting Keap1 and activating Nrf2 pathway
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
9,729 | Dovepress* | 9,326+ | 745 | 10,071 | |
PubMed Central* | 403 | 142 | 545 | ||
Totals | 9,729 | 887 | 10,616 | ||
*Since 22 November 2018 |
View citations on PubMed Central and Google Scholar